FLOWERS FOODS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS
Flowers Foods reported strong financial results for fiscal 2022 and Q4 2022, with sales reaching a record $4.806 billion, up 11.0% year-over-year. Net income increased 10.8% to $228.4 million, while adjusted EBITDA rose 2.3% to $502.0 million. In Q4, sales improved by 10.1% to $1.083 billion, and net income surged 23.6% to $48.6 million. The company expects FY 2023 sales of $5.176 billion to $5.242 billion, indicating a growth range of 7.7% to 9.1%.
CEO Ryals McMullian noted strategic initiatives, including price increases and an acquisition agreement with Papa Pita Bakery to bolster growth and innovation.
- Sales increased 11.0% to $4.806 billion for fiscal 2022.
- Net income rose 10.8% to $228.4 million for fiscal 2022.
- Q4 sales hit a record $1.083 billion, a 10.1% increase.
- Q4 net income surged 23.6% to $48.6 million.
- Company expects FY 2023 sales of $5.176 billion to $5.242 billion.
- Adjusted EBITDA margin decreased 90 basis points to 10.4% of sales.
- Volume declined 6.6% in Q4, affecting sales.
Fiscal 2022 Summary:
Compared to the prior year where applicable
- Sales increased
11.0% to a record .$4.80 6 billion - Net income increased
10.8% to . Adjusted net income increased$228.4 million 3.0% to .$271.0 million - Adjusted EBITDA(1) increased
2.3% to , representing$502.0 million 10.4% of sales, a 90-basis point decrease. - Diluted EPS increased
to$0.10 . Adjusted diluted EPS(1) increased$1.07 to$0.03 .$1.27
Fourth Quarter Summary:
Compared to the prior year fourth quarter where applicable
- Sales increased
10.1% to a quarter-record .$1.08 3 billion - Net income increased
23.6% to . Adjusted net income increased$48.6 million 14.9% to .$48.1 million - Adjusted EBITDA(1) increased
8.5% to , representing$96.2 million 8.9% of sales, a 10-basis point decrease. - Diluted EPS increased
to$0.05 . Adjusted diluted EPS(1) increased$0.23 to$0.03 .$0.23
CEO's Remarks:
"Our record fourth quarter and fiscal year 2022 sales highlight the flexibility of our business model and strong execution by our Flowers team," said Ryals McMullian, president and CEO of
"Building off our achievements in 2022, we are investing in continued growth for this year and beyond. As part of these efforts, we are increasing marketing to support the nationwide launch of our
For the 52-week Fiscal 2023, the Company Expects:
- Sales in the range of approximately
to$5.17 6 billion , representing an increase of approximately$5.24 2 billion7.7% to9.1% compared to the prior year period. - Adjusted EBITDA(2) in the range of approximately
to$513 million .$543 million - Adjusted EPS(2) in the range of approximately
to$1.20 .$1.30
The company's outlook is based on the following assumptions:
- Depreciation and amortization in the range of
to$160 million $165 million - Net interest expense of approximately
to$8 million $12 million - An effective tax rate of approximately
25% - Weighted average diluted share count for the year of approximately 213 million shares
- Capital expenditures in the range of
to$140 million , with$150 million to$20 million related to the ERP upgrade$30 million
Matters Affecting Comparability: | ||||||||
Reconciliation of Earnings per Share to Adjusted Earnings per Share | ||||||||
For the 12-Week | For the 12-Week | |||||||
Net income per diluted common share | $ | 0.23 | $ | 0.18 | ||||
Business process improvement consulting costs | 0.02 | 0.01 | ||||||
Gain on sale and lease termination gain | (0.02) | (0.01) | ||||||
FASTER Act and loss on inferior ingredients | NM | 0.01 | ||||||
Acquisition-related costs | NM | — | ||||||
Pension plan settlement loss | — | NM | ||||||
Adjusted net income per diluted common share | $ | 0.23 | $ | 0.20 |
NM - not meaningful. |
Certain amounts may not add due to rounding. |
Consolidated Fourth Quarter Operating Highlights
Compared to the prior year fourth quarter where applicable
- Sales increased
10.1% to , a fourth quarter record. Pricing/mix(3) increased$1.08 3 billion16.7% while volume(4) declined6.6% . - Branded Retail sales increased
or$49.3 million 7.6% to due to higher prices intended to offset inflationary pressures, partially offset by volume declines. Pricing/mix(3) rose$698.8 million 14.1% while volume(4) declined6.5% . - Other sales increased
or$49.9 million 14.9% to due to higher prices intended to offset inflationary pressures and volume increases in store branded product, partially offset by volume declines in foodservice. Pricing/mix(3) rose$383.9 million 21.5% while volume(4) declined6.6% . - Materials, supplies, labor, and other production costs (exclusive of depreciation and amortization) were
53.2% of sales, a 110-basis point increase. These costs increased as a percentage of sales due to input cost inflation, partially offset by inflation-driven pricing actions, lower incentive compensation expense, and reduced outside purchases of product. - Selling, distribution, and administrative (SD&A) expenses were
37.9% of sales, a 110-basis point decrease, benefiting from lower incentive compensation, lower distributor distribution fees as a percent of sales, reduced rent expense, and greater gain on sale of assets, partly offset by higher bad debt expense and logistics costs. Excluding matters affecting comparability, adjusted SD&A expenses were37.9% of sales, a 100-basis point decrease from the prior year period. - Depreciation and amortization (D&A) expenses were
, or$32.7 million 3.0% of sales, a 20-basis point decrease. - Net income increased
23.6% to due to all the factors mentioned above along with lower interest expense. Adjusted net income increased$48.6 million 14.9% to .$48.1 million - Adjusted EBITDA increased
8.5% to , representing$96.2 million 8.9% of sales, a 10-basis point decrease.
Cash Flow, Capital Allocation, and Capital Return
For fiscal 2022, cash flow from operating activities increased by
During the second quarter of fiscal 2022, the Board of Directors increased the company's share repurchase authorization by 20.0 million shares. For fiscal 2022, the company repurchased
(1) | Adjusted for items affecting comparability. See reconciliations of non-GAAP measures in the financial statements following this release. |
(2) | No reconciliation of the forecasted range for Adjusted EPS to Diluted EPS and adjusted EBITDA to net income for the 52-week Fiscal 2023 is included in this press release because the company is unable to quantify certain amounts that would be required to be included in the GAAP measure without unreasonable efforts. In addition, the company believes such reconciliations would imply a degree of precision that would be confusing or misleading to investors. |
(3) | Calculated as (current year period units X change in price per unit) / prior year period sales dollars |
(4) | Calculated as (prior year period price per unit X change in units) / prior year period sales dollars |
Pre-Recorded Management Remarks and Question and Answer Webcast
In conjunction with this release, pre-recorded management remarks and a supporting slide presentation will be posted to the
About
Headquartered in
Forward-Looking Statements
Statements contained in this filing and certain other written or oral statements made from time to time by
Information Regarding Non-GAAP Financial Measures
The company prepares its consolidated financial statements in accordance with
The company defines EBITDA as earnings before interest, taxes, depreciation and amortization. Earnings are net income. The company believes that EBITDA is a useful tool for managing the operations of its business and is an indicator of the company's ability to incur and service indebtedness and generate free cash flow. EBITDA is used as the primary performance measure in the company's 2014 Omnibus Equity and Incentive Compensation Plan. Furthermore, pursuant to the terms of our credit facility, EBITDA is used to determine the company's compliance with certain financial covenants. The company also believes that EBITDA measures are commonly reported and widely used by investors and other interested parties as measures of a company's operating performance and debt servicing ability because EBITDA measures assist in comparing performance on a consistent basis without regard to depreciation or amortization, which can vary significantly depending upon accounting methods and non-operating factors (such as historical cost). EBITDA is also a widely-accepted financial indicator of a company's ability to incur and service indebtedness.
EBITDA should not be considered an alternative to (a) income from operations or net income (loss) as a measure of operating performance; (b) cash flows provided by operating, investing and financing activities (as determined in accordance with GAAP) as a measure of the company's ability to meet its cash needs; or (c) any other indicator of performance or liquidity that has been determined in accordance with GAAP.
The company defines adjusted EBITDA, EBITDA margin, adjusted EBITDA margin, adjusted net income, adjusted diluted EPS, adjusted income tax expense and adjusted SD&A, respectively, excluding the impact of asset impairment charges, Project Centennial consulting costs, business process improvement costs, lease terminations, legal settlements, acquisition-related costs, and pension plan settlements. The company believes that these measures, when considered together with its GAAP financial results, provides management and investors with a more complete understanding of its business operating results, including underlying trends, by excluding the effects of certain charges.
Presentation of gross margin includes depreciation and amortization in the materials, supplies, labor and other production costs according to GAAP. Our method of presenting gross margin excludes the depreciation and amortization components, as discussed above.
The reconciliations attached provide reconciliations of the non-GAAP measures used in this presentation or release to the most comparable GAAP financial measure.
Condensed Consolidated Balance Sheets | ||||||||
(000's omitted) | ||||||||
Assets | ||||||||
Cash and cash equivalents | $ | 165,134 | $ | 185,871 | ||||
Other current assets | 613,334 | 531,154 | ||||||
Property, plant and equipment, net | 849,325 | 798,728 | ||||||
Right-of-use leases, net | 275,214 | 292,489 | ||||||
Distributor notes receivable (1) | 163,354 | 183,403 | ||||||
Other assets | 37,008 | 20,992 | ||||||
Cost in excess of net tangible assets, net | 1,209,625 | 1,240,676 | ||||||
Total assets | $ | 3,312,994 | $ | 3,253,313 | ||||
Liabilities and Stockholders' Equity | ||||||||
Current liabilities | $ | 518,656 | $ | 471,943 | ||||
Long-term debt | 891,842 | 890,609 | ||||||
Right-of-use lease liabilities (2) | 282,862 | 300,522 | ||||||
Other liabilities | 176,344 | 178,965 | ||||||
Stockholders' equity | 1,443,290 | 1,411,274 | ||||||
Total liabilities and stockholders' equity | $ | 3,312,994 | $ | 3,253,313 | ||||
(1) | Includes current portion of |
(2) | Includes current portion of |
Consolidated Statement of Operations | ||||||||||||||||
(000's omitted, except per share data) | ||||||||||||||||
For the 12-Week | For the 12-Week | For the 52-Week | For the 52-Week | |||||||||||||
Sales | $ | 1,082,670 | $ | 983,490 | $ | 4,805,822 | $ | 4,330,767 | ||||||||
Materials, supplies, labor and other production costs (exclusive of | 575,698 | 512,531 | 2,501,995 | 2,175,247 | ||||||||||||
Selling, distribution, and administrative expenses | 409,929 | 383,542 | 1,850,594 | 1,719,797 | ||||||||||||
FASTER Act and loss on inferior ingredients | 236 | 1,772 | 236 | 944 | ||||||||||||
Plant closure costs and impairment of assets | — | — | 7,825 | — | ||||||||||||
Multi-employer pension plan withdrawal costs | — | — | — | 3,300 | ||||||||||||
Depreciation and amortization expense | 32,713 | 31,874 | 141,957 | 136,559 | ||||||||||||
Income from operations | 64,094 | 53,771 | 303,215 | 294,920 | ||||||||||||
Other pension benefit | (179) | (93) | (773) | (405) | ||||||||||||
Pension plan settlement loss | — | 403 | — | 403 | ||||||||||||
Loss on extinguishment of debt | — | — | — | 16,149 | ||||||||||||
Interest expense, net | 330 | 1,419 | 5,277 | 8,001 | ||||||||||||
Income before income taxes | 63,943 | 52,042 | 298,711 | 270,772 | ||||||||||||
Income tax expense | 15,346 | 12,720 | 70,317 | 64,585 | ||||||||||||
Net income | $ | 48,597 | $ | 39,322 | $ | 228,394 | $ | 206,187 | ||||||||
Net income per diluted common share | $ | 0.23 | $ | 0.18 | $ | 1.07 | $ | 0.97 | ||||||||
Diluted weighted average shares outstanding | 212,925 | 213,165 | 213,227 | 213,033 |
Condensed Consolidated Statement of Cash Flows | ||||||||||||||||
(000's omitted) | ||||||||||||||||
For the 12-Week | For the 12-Week | For the 52-Week | For the 52-Week | |||||||||||||
Cash flows from operating activities: | ||||||||||||||||
Net income | $ | 48,597 | $ | 39,322 | $ | 228,394 | $ | 206,187 | ||||||||
Adjustments to reconcile net income to net cash from operating | ||||||||||||||||
Total non-cash adjustments | 25,976 | 41,781 | 183,490 | 172,430 | ||||||||||||
Changes in assets and liabilities and pension plan contributions | (5,218) | (51,716) | (50,995) | (34,007) | ||||||||||||
Net cash provided by operating activities | 69,355 | 29,387 | 360,889 | 344,610 | ||||||||||||
Cash flows from investing activities: | ||||||||||||||||
Purchase of property, plant and equipment | (40,699) | (49,241) | (169,071) | (135,964) | ||||||||||||
Purchase of leased portfolio | — | (64,689) | — | (64,689) | ||||||||||||
Proceeds from sale of property, plant and equipment | 4,346 | 470 | 7,681 | 2,995 | ||||||||||||
Investment in unconsolidated affiliate | — | — | (9,000) | — | ||||||||||||
Acquisition of trademarks | — | — | — | (10,200) | ||||||||||||
Other | 4,521 | 3,736 | 19,302 | 16,420 | ||||||||||||
Net cash disbursed for investing activities | (31,832) | (109,724) | (151,088) | (191,438) | ||||||||||||
Cash flows from financing activities: | ||||||||||||||||
Dividends paid | (46,449) | (44,393) | (186,501) | (175,903) | ||||||||||||
Stock repurchases | — | — | (34,586) | (9,510) | ||||||||||||
Net change in debt borrowings | — | — | — | (81,858) | ||||||||||||
Payments on financing leases | (291) | (434) | (1,597) | (1,745) | ||||||||||||
Other | 1,607 | 3,512 | 517 | (5,761) | ||||||||||||
Net cash disbursed for financing activities | (45,133) | (41,315) | (222,167) | (274,777) | ||||||||||||
Effect of exchange rates on cash | — | — | (8,371) | — | ||||||||||||
Net decrease in cash and cash equivalents | (7,610) | (121,652) | (12,366) | (121,605) | ||||||||||||
Cash and cash equivalents at beginning of period | 172,744 | 307,523 | 185,871 | 307,476 | ||||||||||||
Cash and cash equivalents at end of period | $ | 165,134 | $ | 185,871 | $ | 165,134 | $ | 185,871 |
Sales by Sales Class and | ||||||||||||||||
(000's omitted) | ||||||||||||||||
Sales by Sales Class | For the 12-Week | For the 12-Week | ||||||||||||||
$ Change | % Change | |||||||||||||||
Branded Retail | $ | 698,795 | $ | 649,517 | $ | 49,278 | 7.6 | % | ||||||||
Other | 383,875 | 333,973 | 49,902 | 14.9 | % | |||||||||||
Total Sales | $ | 1,082,670 | $ | 983,490 | $ | 99,180 | 10.1 | % |
Sales by Sales Class | For the 52-Week | For the 52-Week | ||||||||||||||
$ Change | % Change | |||||||||||||||
Branded Retail | $ | 3,139,220 | $ | 2,874,714 | $ | 264,506 | 9.2 | % | ||||||||
Other | 1,666,602 | 1,456,053 | 210,549 | 14.5 | % | |||||||||||
Total Sales | $ | 4,805,822 | $ | 4,330,767 | $ | 475,055 | 11.0 | % |
For the 12-week period ended | Branded Retail | Other | Total | |||||||||
Pricing/mix* | 14.1 | % | 21.5 | % | 16.7 | % | ||||||
Volume* | (6.5) | % | (6.6) | % | (6.6) | % | ||||||
Total percentage point change in sales | 7.6 | % | 14.9 | % | 10.1 | % |
For the 52-week period ended | Branded Retail | Other | Total | |||||||||
Pricing/mix* | 14.3 | % | 18.1 | % | 15.4 | % | ||||||
Volume* | (5.1) | % | (3.6) | % | (4.4) | % | ||||||
Total percentage point change in sales | 9.2 | % | 14.5 | % | 11.0 | % | ||||||
* Computations above are calculated as follows: | ||||||||||||
Price/Mix $ = Current year period units × change in price per unit | ||||||||||||
Price/Mix % = Price/Mix $ ÷ Prior year period Sales $ | ||||||||||||
Volume $ = Prior year period price per unit × change in units | ||||||||||||
Volume % = Volume $ ÷ Prior year period Sales $ |
Reconciliation of GAAP to Non-GAAP Measures | ||||||||||||||||
(000's omitted, except per share data) | ||||||||||||||||
Reconciliation of Earnings per Share to Adjusted Earnings per Share | ||||||||||||||||
For the 12-Week | For the 12-Week | For the 52-Week | For the 52-Week | |||||||||||||
Net income per diluted common share | $ | 0.23 | $ | 0.18 | $ | 1.07 | $ | 0.97 | ||||||||
Business process improvement consulting costs | 0.02 | 0.01 | 0.12 | 0.11 | ||||||||||||
Plant closure costs and impairment of assets | — | — | 0.03 | — | ||||||||||||
Gain on sale, severance costs, and lease termination (gain) loss | (0.02) | (0.01) | (0.02) | (0.01) | ||||||||||||
FASTER Act and loss on inferior ingredients | NM | 0.01 | NM | NM | ||||||||||||
Acquisition-related costs | NM | — | 0.04 | — | ||||||||||||
Acquisition consideration adjustment | — | — | — | 0.01 | ||||||||||||
Legal settlements and related costs | — | — | 0.03 | 0.08 | ||||||||||||
Loss on extinguishment of debt | — | — | — | 0.06 | ||||||||||||
Pension plan settlement loss | — | NM | — | NM | ||||||||||||
Multi-employer pension plan withdrawal costs | — | — | — | 0.01 | ||||||||||||
Adjusted net income per diluted common share | $ | 0.23 | $ | 0.20 | $ | 1.27 | $ | 1.24 | ||||||||
NM - not meaningful. | ||||||||||||||||
Certain amounts may not add due to rounding. |
Reconciliation of Gross Margin | ||||||||||||||||
For the 12-Week | For the 12-Week | For the 52-Week | For the 52-Week | |||||||||||||
Sales | $ | 1,082,670 | $ | 983,490 | $ | 4,805,822 | $ | 4,330,767 | ||||||||
Materials, supplies, labor and other production costs (exclusive | 575,698 | 512,531 | 2,501,995 | 2,175,247 | ||||||||||||
Gross margin excluding depreciation and amortization | 506,972 | 470,959 | 2,303,827 | 2,155,520 | ||||||||||||
Less depreciation and amortization for production activities | 18,085 | 17,917 | 77,950 | 76,904 | ||||||||||||
Gross margin | $ | 488,887 | $ | 453,042 | $ | 2,225,877 | $ | 2,078,616 | ||||||||
Depreciation and amortization for production activities | $ | 18,085 | $ | 17,917 | $ | 77,950 | $ | 76,904 | ||||||||
Depreciation and amortization for selling, distribution, and | 14,628 | 13,957 | 64,007 | 59,655 | ||||||||||||
Total depreciation and amortization | $ | 32,713 | $ | 31,874 | $ | 141,957 | $ | 136,559 |
Reconciliation of Selling, Distribution, and Administrative Expenses to | ||||||||||||||||
For the 12-Week | For the 12-Week | For the 52-Week | For the 52-Week | |||||||||||||
Selling, distribution, and administrative expenses | $ | 409,929 | $ | 383,542 | $ | 1,850,594 | $ | 1,719,797 | ||||||||
Business process improvement consulting costs | (4,303) | (3,897) | (33,169) | (31,293) | ||||||||||||
Gain on sale, severance costs, and lease termination | 6,107 | 2,644 | 4,390 | 2,644 | ||||||||||||
Legal settlements and related costs | — | — | (7,500) | (23,089) | ||||||||||||
Acquisition-related costs | (936) | — | (12,518) | — | ||||||||||||
Acquisition consideration adjustment | — | — | — | (3,400) | ||||||||||||
Adjusted SD&A | $ | 410,797 | $ | 382,289 | $ | 1,801,797 | $ | 1,664,659 |
Reconciliation of GAAP to Non-GAAP Measures | ||||||||||||||||
(000's omitted, except per share data) | ||||||||||||||||
Reconciliation of Net Income to EBITDA and Adjusted EBITDA | ||||||||||||||||
For the 12-Week | For the 12-Week | For the 52-Week | For the 52-Week | |||||||||||||
Net income | $ | 48,597 | $ | 39,322 | $ | 228,394 | $ | 206,187 | ||||||||
Income tax expense | 15,346 | 12,720 | 70,317 | 64,585 | ||||||||||||
Interest expense, net | 330 | 1,419 | 5,277 | 8,001 | ||||||||||||
Loss on extinguishment of debt | — | — | — | 16,149 | ||||||||||||
Depreciation and amortization | 32,713 | 31,874 | 141,957 | 136,559 | ||||||||||||
EBITDA | 96,986 | 85,335 | 445,945 | 431,481 | ||||||||||||
Other pension benefit | (179) | (93) | (773) | (405) | ||||||||||||
Business process improvement consulting costs | 4,303 | 3,897 | 33,169 | 31,293 | ||||||||||||
Plant closure costs and impairment of assets | — | — | 7,825 | — | ||||||||||||
Gain on sale, severance costs, and lease termination (gain) | (6,107) | (2,644) | (4,390) | (2,644) | ||||||||||||
FASTER Act and loss on inferior ingredients | 236 | 1,772 | 236 | 944 | ||||||||||||
Acquisition-related costs | 936 | — | 12,518 | — | ||||||||||||
Acquisition consideration adjustment | — | — | — | 3,400 | ||||||||||||
Legal settlements and related costs | — | — | 7,500 | 23,089 | ||||||||||||
Pension plan settlement loss | — | 403 | — | 403 | ||||||||||||
Multi-employer pension plan withdrawal costs | — | — | — | 3,300 | ||||||||||||
Adjusted EBITDA | $ | 96,175 | $ | 88,670 | $ | 502,030 | $ | 490,861 | ||||||||
Sales | $ | 1,082,670 | $ | 983,490 | $ | 4,805,822 | $ | 4,330,767 | ||||||||
Adjusted EBITDA margin | 8.9 | % | 9.0 | % | 10.4 | % | 11.3 | % |
Reconciliation of Income Tax Expense to Adjusted Income Tax Expense | ||||||||||||||||
For the 12-Week | For the 12-Week | For the 52-Week | For the 52-Week | |||||||||||||
Income tax expense | $ | 15,346 | $ | 12,720 | $ | 70,317 | $ | 64,585 | ||||||||
Tax impact of: | ||||||||||||||||
Business process improvement consulting costs | 1,075 | 974 | 8,292 | 7,823 | ||||||||||||
Plant closure costs and impairment of assets | — | — | 1,956 | — | ||||||||||||
Gain on sale, severance costs, and lease termination (gain) loss | (1,527) | (661) | (1,098) | (661) | ||||||||||||
FASTER Act and loss on inferior ingredients | 59 | 443 | 59 | 236 | ||||||||||||
Acquisition-related costs | 234 | — | 3,130 | — | ||||||||||||
Acquisition consideration adjustment | — | — | — | 850 | ||||||||||||
Legal settlements and related costs | — | — | 1,875 | 5,773 | ||||||||||||
Loss on extinguishment of debt | — | — | — | 4,037 | ||||||||||||
Pension plan settlement loss | — | 101 | — | 101 | ||||||||||||
Multi-employer pension plan withdrawal costs | — | — | — | 825 | ||||||||||||
Adjusted income tax expense | $ | 15,187 | $ | 13,577 | $ | 84,531 | $ | 83,569 |
Reconciliation of GAAP to Non-GAAP Measures | ||||||||||||||||
(000's omitted, except per share data) | ||||||||||||||||
Reconciliation of Net Income to Adjusted Net Income | ||||||||||||||||
For the 12-Week | For the 12-Week | For the 52-Week | For the 52-Week | |||||||||||||
Net income | $ | 48,597 | $ | 39,322 | $ | 228,394 | $ | 206,187 | ||||||||
Business process improvement consulting costs | 3,228 | 2,923 | 24,877 | 23,470 | ||||||||||||
Plant closure costs and impairment of assets | — | — | 5,869 | — | ||||||||||||
Gain on sale, severance costs, and lease termination (gain) loss | (4,580) | (1,983) | (3,292) | (1,983) | ||||||||||||
FASTER Act and loss on inferior ingredients | 177 | 1,329 | 177 | 708 | ||||||||||||
Acquisition-related costs | 702 | — | 9,388 | — | ||||||||||||
Acquisition consideration adjustment | — | — | — | 2,550 | ||||||||||||
Legal settlements and related costs | — | — | 5,625 | 17,316 | ||||||||||||
Loss on extinguishment of debt | — | — | — | 12,112 | ||||||||||||
Pension plan settlement loss | — | 302 | — | 302 | ||||||||||||
Multi-employer pension plan withdrawal costs | — | — | — | 2,475 | ||||||||||||
Adjusted net income | $ | 48,124 | $ | 41,893 | $ | 271,038 | $ | 263,137 |
View original content:https://www.prnewswire.com/news-releases/flowers-foods-inc-reports-fourth-quarter-and-full-year-2022-results-301743052.html
SOURCE
FAQ
What were Flowers Foods' financial results for Q4 2022?
What is the expected sales growth for Flowers Foods in FY 2023?
How did Flowers Foods perform in fiscal 2022?